RxDoctor Payments Data

Kierstyn Lomprey

Nurse Practitioner · Fond du Lac, WINPI 1033785530

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 83.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $2,464 and has fallen 75.7% since, to $600 in 2025. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,779in general payments, 2019–2025

Across 46 payments — averaging $82.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$334
  • Boehringer Ingelheim$125
  • Cvrx, Inc.$62
  • Abbott$53
  • Actelion Pharmaceuticals US, Inc.$24
  • plus $41 from 2 others

What the payments were for

  • Travel & lodging$1,86449%
  • Food & beverage$1,91551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,779 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$30,037
Medicare patients
234
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban441$522,346
XareltoRivaroxaban68$65,113
Metoprolol Succinate434$8,506
Diltiazem 24hr Er (Cd)Diltiazem Hcl188$6,278
Flecainide Acetate56$1,611
Amiodarone Hcl122$1,460
Metoprolol Tartrate139$1,392
Diltiazem 24hr ErDiltiazem Hcl34$1,232
Warfarin Sodium48$888
Diltiazem Hcl26$543
Bisoprolol Fumarate13$345
Carvedilol39$274
ClopidogrelClopidogrel Bisulfate23$150
SotalolSotalol Hcl19$97

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Fond du Lac

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →